Taken together, our study shows that CTLA4 inhibits the proliferation/survival of CLL cells via regulation of the expression of STAT1, NFATC2, c-Fos, c-Myc and Bcl-2. This evidence concerns the gene FOS and B-cell chronic lymphocytic leukemia.